← Leaderboards

Christopher Mark Norris

University Of Kentucky

Google Scholar ↗PubMed ↗ORCID ↗

$15,768,108

Attributed

$20,997,521

Total exposure

15

Grants

10

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $9.9M · FY2005–25

$10M$7.5M$5M$2.5M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$38,071,249 · 16

By mechanism

P01$20,865,096 · 5

R01$9,256,916 · 3

RF1$6,874,966 · 3

K01$430,040 · 1

R21$413,875 · 1

F32$127,660 · 1

Top collaborators

Most similar at University Of Kentucky

Same institution · by research overlap

Peter T Nelson$21,085,191
Adam D Bachstetter$7,223,838
Gregory A Jicha$17,898,620
Frederick Schmitt$9,256,885
Olivier Thibault$6,789,321

Others in their field

Top investigators on “Alzheimer&Apos”

Jose A Luchsinger · Columbia University Health Sciences$56,595,040
Eric M Reiman · Banner Health$48,982,487
Yadong Huang · J. David Gladstone Institutes$40,311,515
Lindsay A. Farrer · Boston University Medical Campus$34,189,802
David M Holtzman · Washington University$28,985,806
Michael W Weiner · Northern California Institute Res &Educ$28,197,224

Research focus

Alzheimer&AposSignal TransductionMouse ModelS DiseaseNeuronsAnimalsBrainAgingNeuroinflammationFunctional DisorderElectrophysiology (Science)AstrocytesCalcineurinCellsS Disease ModelPathologyInflammatorySynapsesBiological MarkersImpaired CognitionSynaptic FunctionPathway InteractionsBehavioralNerve Degeneration

Grant awards (53)

Strategies for targeting astrocyte reactivity in Alzheimer's disease and related dementias$3,958,139

P01 · FY2025 · AG · contact PI

Preclinical evaluation of tacrolimus in a canine model of Alzheimer's disease$896,872

R01 · FY2025 · AG

Project 3 - Astrocytic glutamate dysregulation in AD and VCID$583,448

P01 · FY2025 · AG · contact PI

Neuronal IL-1R1 Signaling in Mild Closed Head Injury$418,876

R01 · FY2025 · NS

Core A - Administrative Core$230,053

P01 · FY2025 · AG · contact PI

Strategies for Targeting Astrocyte Reactivity in Alzheimer's Disease and Related Dementias$230,000

P01 · FY2025 · AG · contact PI

Strategies for targeting astrocyte reactivity in Alzheimer's disease and related dementias$4,131,531

P01 · FY2024 · AG · contact PI

Project 3 - Astrocytic glutamate dysregulation in AD and VCID$607,229

P01 · FY2024 · AG · contact PI

Neuronal IL-1R1 Signaling in Mild Closed Head Injury$406,308

R01 · FY2024 · NS

Core A - Administrative Core$250,717

P01 · FY2024 · AG · contact PI

Strategies for targeting astrocyte reactivity in Alzheimer's disease and related dementias$4,150,513

P01 · FY2023 · AG · contact PI

Project 3 - Astrocytic glutamate dysregulation in AD and VCID$621,917

P01 · FY2023 · AG · contact PI

Neuronal IL-1R1 Signaling in Mild Closed Head Injury$429,134

R01 · FY2023 · NS

Core A - Administrative Core$380,773

P01 · FY2023 · AG · contact PI

Strategies for targeting astrocyte reactivity in Alzheimer's disease and related dementias.$380,773

P01 · FY2023 · AG · contact PI

Core A - Administrative Core$243,067

P01 · FY2023 · AG · contact PI

Strategies for targeting astrocyte reactivity in Alzheimer's disease and related dementias$4,222,772

P01 · FY2022 · AG · contact PI

Preclinical evaluation of tacrolimus in a canine model of Alzheimer's disease$4,083,505

RF1 · FY2022 · AG

Project 3 - Astrocytic glutamate dysregulation in AD and VCID$631,097

P01 · FY2022 · AG · contact PI

Neuronal IL-1R1 Signaling in Mild Closed Head Injury$442,384

R01 · FY2022 · NS

Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease$249,287

RF1 · FY2022 · AG · contact PI

Core A - Administrative Core$243,067

P01 · FY2022 · AG · contact PI

Preclinical evaluation of tacrolimus in a canine model of Alzheimer's disease$382,500

R01 · FY2021 · AG

Preclinical evaluation of tacrolimus in a canine model of Alzheimer's disease$313,926

R01 · FY2021 · AG

Preclinical evaluation of tacrolimus in a canine model of Alzheimer's disease$552,574

R01 · FY2020 · AG

Preclinical evaluation of tacrolimus in a canine model of Alzheimer's disease$752,131

R01 · FY2019 · AG

Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease$2,338,540

RF1 · FY2018 · AG · contact PI

Preclinical evaluation of tacrolimus in a canine model of Alzheimer's disease$746,016

R01 · FY2018 · AG

Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease$378,371

R01 · FY2018 · AG · contact PI

Astrocytic connexin 43 modulation in AD$188,125

R21 · FY2018 · AG · contact PI

Preclinical evaluation of tacrolimus in a canine model of Alzheimer's disease$763,089

R01 · FY2017 · AG

Astrocytic connexin 43 modulation in AD$225,750

R21 · FY2017 · AG · contact PI

Inflammation and Renin-Angiotensin System Dysfunction as risk factors for AD$203,634

RF1 · FY2017 · AG

Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease$299,136

R01 · FY2016 · AG · contact PI

Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease$290,392

R01 · FY2015 · AG · contact PI

Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease$299,613

R01 · FY2014 · AG · contact PI

Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease$283,472

R01 · FY2013 · AG · contact PI

Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease$300,329

R01 · FY2012 · AG · contact PI

Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease$254,633

R01 · FY2010 · AG · contact PI

Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease$257,206

R01 · FY2009 · AG · contact PI

Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease$257,206

R01 · FY2008 · AG · contact PI

Calcineurin and Biobehavioral Markers of Brain Aging$91,166

K01 · FY2008 · AG · contact PI

Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease$262,455

R01 · FY2007 · AG · contact PI

Calcineurin and Biobehavioral Markers of Brain Aging$88,511

K01 · FY2007 · AG · contact PI

ROLE OF CALCINEURIN IN ASTROCYTE ACTIVATION ASSOCIATED WITH ALZHEIMER?S DISEASE$29,215

P20 · FY2007 · RR · contact PI

Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease$270,293

R01 · FY2006 · AG · contact PI

Calcineurin and Biobehavioral Markers of Brain Aging$85,933

K01 · FY2006 · AG · contact PI

ROLE OF CALCINEURIN IN ASTROCYTE ACTIVATION ASSOCIATED WITH ALZHEIMER?S DISEASE$73,481

P20 · FY2006 · RR · contact PI

Calcineurin and Biobehavioral Markers of Brain Aging$83,430

K01 · FY2005 · AG

Calcineurin and Biobehavioral Markers of Brain Aging$81,000

K01 · FY2004 · AG

CALCINEURIN IN CALCIUM CHANNEL REGULATION DURING AGING.$48,148

F32 · FY2002 · AG

CALCINEURIN IN CALCIUM CHANNEL REGULATION DURING AGING.$41,996

F32 · FY2001 · AG

CALCINEURIN IN CALCIUM CHANNEL REGULATION DURING AGING.$37,516

F32 · FY2000 · AG